Citigroup’s Instil Bio TIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$677 Buy
+88
New +$710 ﹤0.01% 5439
2025
Q4
Sell
-1
Closed -$18 6471
2025
Q3
$18 Hold
1
﹤0.01% 5912
2025
Q2
$21 Sell
1
-1
-50% -$21 ﹤0.01% 5571
2025
Q1
$35 Sell
2
-2,841
-100% -$58.9K ﹤0.01% 5462
2024
Q4
$54.3K Sell
2,843
-2,887
-50% -$88K ﹤0.01% 5065
2024
Q3
$386K Buy
5,730
+5,615
+4,883% +$132K ﹤0.01% 3896
2024
Q2
$1.18K Buy
115
+113
+5,650% +$1.22K ﹤0.01% 5373
2024
Q1
$22 Hold
2
﹤0.01% 5545
2023
Q4
$15 Sell
2
-85
-98% -$615 ﹤0.01% 5625
2023
Q3
$746 Sell
87
-67
-44% -$675 ﹤0.01% 5143
2023
Q2
$1.7K Sell
154
-201,333
-100% -$2.46M ﹤0.01% 5307
2023
Q1
$2.66M Buy
201,487
+201,366
+166,418% +$2.98M ﹤0.01% 1834
2022
Q4
$1.53K Sell
121
-43
-26% -$2.13K ﹤0.01% 5318
2022
Q3
$15K Sell
164
-180
-52% -$20.6K ﹤0.01% 4856
2022
Q2
$32K Buy
344
+99
+40% +$14K ﹤0.01% 4763
2022
Q1
$53K Sell
245
-630
-72% -$147K ﹤0.01% 4703
2021
Q4
$299K Buy
875
+706
+418% +$273K ﹤0.01% 4120
2021
Q3
$61K Buy
169
+128
+312% +$47.8K ﹤0.01% 4640
2021
Q2
$16K Buy
+41
New +$15.2K ﹤0.01% 5438

Other funds holding TIL

Citigroup's TIL Position: Q2 2026 in Review

Citigroup opened a new position in Instil Bio (TIL) in Q2 2026: 88 shares worth $677. The stake represents ﹤0.01% of the portfolio and ranks #5439 among its holdings. This is a return to the name: Citigroup previously reported a position in TIL as recently as Q3 2025.

Citigroup first reported a position in TIL in Q2 2021 and has held it in 19 quarters since. The position peaked at $2.66M in Q1 2023. 26 funds tracked by Wall St. Rank hold TIL as of Q2 2026.

  • Citigroup held 88 shares of Instil Bio worth $677 as of Q2 2026.
  • Instil Bio was a new Citigroup position in Q2 2026.
  • Instil Bio made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5439 holding.
  • Citigroup first reported a position in Instil Bio in Q2 2021 and has held it in 19 quarters since.
  • Citigroup's Instil Bio position peaked at $2.66M in Q1 2023.
  • 26 funds tracked by Wall St. Rank held Instil Bio as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.